Cargando…

Autologous cytokine-induced killer cell transfusion increases overall survival in advanced pancreatic cancer

BACKGROUND: Advanced pancreatic cancer (PC) has very poor prognosis with present treatments, thus necessitating continued efforts to find improved therapeutic approaches. Both preclinical and preliminary clinical data indicate that cytokine-induced killer (CIK) cells are an effective tool against va...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Zibing, Liu, Yuqing, Li, Rui’e, Shang, Yiman, Zhang, Yong, Zhao, Lingdi, Li, Wei, Yang, Yonghao, Zhang, Xiaojie, Yang, Tiejun, Nie, Changfu, Han, Feng, Liu, Ying, Luo, Suxia, Gao, Quanli, Song, Yongping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4740990/ https://www.ncbi.nlm.nih.gov/pubmed/26842696 http://dx.doi.org/10.1186/s13045-016-0237-6

Ejemplares similares

High Complete Response Rate in Patients With Metastatic Renal Cell Carcinoma Receiving Autologous Cytokine-Induced Killer Cell Therapy Plus Anti-Programmed Death-1 Agent: A Single-Center Study
por: Zhao, Lingdi, et al.
Publicado: (2022)

MDSC-decreasing chemotherapy increases the efficacy of cytokine-induced killer cell immunotherapy in metastatic renal cell carcinoma and pancreatic cancer
por: Wang, Zibing, et al.
Publicado: (2015)

Sintilimab maintenance therapy post first-line cytokine-induced killer cells plus chemotherapy for extensive-stage small cell lung cancer
por: Ma, Baozhen, et al.
Publicado: (2022)

Axitinib Reverses Resistance to Anti-Programmed Cell Death-1 Therapy in a Patient With Renal Cell Carcinoma
por: Yang, Yonghao, et al.
Publicado: (2021)

Clinical effects of autologous cytokine-induced killer cell-based immunotherapy in the treatment of endometrial cancer: a case report and literature review
por: Zhang, Yong, et al.
Publicado: (2017)

The Sequence of Chemotherapy and Toripalimab Might Influence the Efficacy of Neoadjuvant Chemoimmunotherapy in Locally Advanced Esophageal Squamous Cell Cancer—A Phase II Study
por: Xing, Wenqun, et al.
Publicado: (2021)

Combination of Low-Dose Gemcitabine and PD-1 Inhibitors for Treatment in Patients With Advanced Malignancies
por: Huang, Hao, et al.
Publicado: (2022)

Long-term survival of a patient with microsatellite-stable refractory colorectal cancer with regorafenib and PD-1 inhibitor sintilimab: a case report and review of literature
por: Zhang, Yong, et al.
Publicado: (2021)

Combination of Cytokine-Induced Killer Cells and Programmed Cell Death-1 Blockade Works Synergistically to Enhance Therapeutic Efficacy in Metastatic Renal Cell Carcinoma and Non-Small Cell Lung Cancer
por: Wang, Zibing, et al.
Publicado: (2018)

Chemotherapy Reverses Anti-PD-1 Resistance in One Patient With Advanced Non-small Lung Cell Cancer
por: Zhao, Lingdi, et al.
Publicado: (2020)

Advanced Renal-Cell Carcinoma Pseudoprogression After Combined Immunotherapy: Case Report and Literature Review
por: Zhang, Xiaojie, et al.
Publicado: (2021)

Toxic Epidermal Necrolysis-Like Reaction Following Combination Therapy With Camrelizumab and Apatinib for Advanced Gallbladder Carcinoma
por: Yang, Yonghao, et al.
Publicado: (2021)

Factors Influencing the Efficacy of Anti-PD-1 Therapy in Chinese Patients with Advanced Melanoma
por: Zhao, Lingdi, et al.
Publicado: (2019)

Pretreatment Peripheral B Cells Are Associated With Tumor Response to Anti-PD-1-Based Immunotherapy
por: Yuan, Shumin, et al.
Publicado: (2020)

Transfusion‐induced platelet antibodies and regulatory T cells in multiply transfused patients
por: Song, Tiejun, et al.
Publicado: (2021)

Autologous hematopoietic stem cell infusion for sustained myelosuppression after BCMA–CAR-T therapy in patient with relapsed myeloma
por: Lin, Quande, et al.
Publicado: (2019)

Efficacy and safety of trastuzumab as maintenance or palliative therapy in advanced HER2-positive gastric cancer
por: Fu, Xiaomin, et al.
Publicado: (2018)

Randomized, multicenter, open-label trial of autologous cytokine-induced killer cell immunotherapy plus chemotherapy for squamous non-small-cell lung cancer: NCT01631357
por: Liu, Liang, et al.
Publicado: (2020)

Does Autologous Transfusion Decrease Allogeneic Transfusion in Liposuction Surgery of Lymphedema Patients?
por: Chen, Linfeng, et al.
Publicado: (2022)

A review of the application of autologous blood transfusion
por: Zhou, J.
Publicado: (2016)

Efficacy and Safety of Apatinib in Patients with Recurrent or Refractory Melanoma
por: Yuan, Shumin, et al.
Publicado: (2022)

Repeated Autologous Bone Marrow Transfusion through Portal Vein for Treating Decompensated Liver Cirrhosis after Splenectomy
por: Zhang, Weiwei, et al.
Publicado: (2018)

Angiogenesis inhibitors rechallenge in patients with advanced non-small-cell lung cancer: a pooled analysis of randomized controlled trials
por: Zhao, Lingdi, et al.
Publicado: (2015)

A Comparison of Autologous and Homologous Transfusions in Spinal Fusion
por: Park, Moon-Soo, et al.
Publicado: (2006)

Autologous blood transfusion in trauma: a literature review
por: McKenna, John E
Publicado: (2015)

Intraoperative cell salvage with autologous transfusion in liver transplantation
por: Pinto, Marcelo A, et al.
Publicado: (2019)

Culturing adequate CAR-T cells from less peripheral blood to treat B-cell malignancies
por: Han, Lu, et al.
Publicado: (2021)

The Efficacy and Safety of Autologous Transfusion in Unilateral Total Knee Arthroplasty
por: Yoo, Moon-Jib, et al.
Publicado: (2015)

Circulating microRNAs as Biomarkers for Detection of Autologous Blood Transfusion
por: Leuenberger, Nicolas, et al.
Publicado: (2013)

The effectiveness of providing autologous transfusion education to operating room staff
por: Chegini, Azita, et al.
Publicado: (2017)

The importance of autologous blood transfusion in lung transplantation and cardiovascular surgeries
por: Akçam, Tevfik İlker, et al.
Publicado: (2021)

Characterization of the killer cell generated in the autologous mixed leukocyte reaction
Publicado: (1983)

Danggui Buxue Tang Rescues Folliculogenesis and Ovarian Cell Apoptosis in Rats with Premature Ovarian Insufficiency
por: Wang, Lingdi, et al.
Publicado: (2021)

Adjuvant treatment for triple-negative breast cancer: a retrospective study of immunotherapy with autologous cytokine-induced killer cells in 294 patients
por: Zhang, Yuhan, et al.
Publicado: (2019)

T-cell immunoglobulin and mucin domain-containing protein-3 and galectin-9 protein expression: Potential prognostic significance in esophageal squamous cell carcinoma for Chinese patients
por: Hou, Nan, et al.
Publicado: (2017)

Increased body mass index is associated with improved overall survival in extranodal natural killer/T-cell lymphoma, nasal type
por: Li, Ya-Jun, et al.
Publicado: (2016)

Application of Salvage Autologous Blood Transfusion for treating Massive Hemorrhage during Ectopic Pregnancy
por: Li, Junying, et al.
Publicado: (2022)

Clinical, haematological and biochemical responses of sheep undergoing autologous blood transfusion
por: Sousa, Rejane Santos, et al.
Publicado: (2012)

Treatment of solid tumor with autologous natural killer cells in mouse models
por: Liao, Nan-Shih
Publicado: (2014)

Efficacy of Tumor-Infiltrating Lymphocytes Combined with IFN-α in Chinese Resected Stage III Malignant Melanoma
por: Li, Wei, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ft6tjlp2u0rdhuaa5g885iiig4